Retinoblastoma management remains complex, requiring individualized treatment based on
International Classification of Retinoblastoma (ICRB) staging, germline mutation status …

The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …

Objective To analyze our 5-year experience of intra-arterial chemotherapy (IAC) for
retinoblastoma as primary or secondary therapy. Design Retrospective interventional case …

In this report, we explore retinoblastoma diagnostic accuracy and review chemotherapy
alternatives for retinoblastoma using intravenous, intra-arterial, periocular, and intravitreal …

Abstract Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery
chemotherapy or chemosurgery, is currently widely accepted as one of the primary treatment …

Purpose To report globe salvage rates, patient survival and adverse events of ophthalmic
artery chemosurgery (OAC) for International Classification of Retinoblastoma (ICRB) group …

Retinoblastoma is the most common primary intraocular malignancy of childhood. It typically
presents with leukocoria or strabismus. In later stages of the disease, the child may exhibit …

PURPOSE: To determine the correlation between the International Classification of
Retinoblastoma (ICRB) and histopathologic high-risk retinoblastoma. DESIGN …

Background Super-selected intra-arterial chemotherapy has increasingly been used as
conservative management for retinoblastoma during the past decade. However, the …

Retinoblastoma is a deadly eye cancer in children, leading to death in 50%–70% of children
in undeveloped nations who are diagnosed with it. This malignancy is the most common …